Silence Therapeutics was required to file disclosures with the Securities and Exchange Commission on July 31, 2026.
1 report, 1 independent
Updated Jul 31
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Silence Therapeutics was required to file disclosures with the Securities and Exchange Commission on July 31, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Silence Therapeutics
UK business
Nothing else this week.
-
Securities and Exchange Commission
government agency of the Philippines
Related events
- The European Equity Fund, Inc. filed disclosures with the SEC regarding its investments in European companies.
- F5, Inc. filed disclosures regarding share purchases with the Securities and Exchange Commission.
- Millicom International Cellular SA filed disclosures regarding share holdings with the Securities and Exchange Commission on July 25, 2026.
- Cheniere Energy filed disclosures regarding its operations with the Securities and Exchange Commission on June 6, 2026.
- GT Biopharma filed with the SEC regarding institutional investment, and its stock traded on the Nasdaq exchange.